Physician profile
Ryan Stevens
NPI 1417938309
$1,361.16
in general payments reported to CMS, 2019-2025
17 companies · $216 in 2025
The $216 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.07 · 2020: $55.08 · 2021: $23.57 · 2022: $85.86 · 2023: $371 · 2024: $572 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,158.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $502.78 | 2022-2025 | |
| Glaxosmithkline, LLC. | $168.99 | 2021-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $138.78 | 2024-2025 | Dupixent |
| Phathom Pharmaceuticals, INC. | $126.48 | 2024 | Voquezna |
| Abbvie INC. | $123.90 | 2023 | |
| Stryker Corporation | $78.90 | 2019-2024 | 1788, Scopis Ent |
| Medtronic, INC. | $55.59 | 2023 | Nuvent, Alar |
| Karl Storz Endoscopy-America | $27.25 | 2023 | |
| Alk-Abello, INC | $21.74 | 2019 | |
| Livanova USA, INC. | $17.96 | 2025 | Vns Therapy Sentiva Model 1000 Generator |
| Genentech USA, INC. | $16.51 | 2023 | Xolair |
| Intersect Ent, INC. | $16.22 | 2022 | |
| Acclarent, INC | $15.87 | 2020 | |
| Aerin Medical INC. | $13.02 | 2022 | |
| Optinose US, INC. | $12.95 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $12.16 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Stevens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.